{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T03:54:05Z","timestamp":1775620445165,"version":"3.50.1"},"reference-count":33,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Elevated human epididymis secretory protein 4 (HE4) serum levels have been widely investigated in patients with\novarian cancer. However, high levels of HE4 can be also found in other tumors and in renal fibrosis. To date, the HE4 assay manufacturer\nfeatures the reference value only for the female pre- and post-menopausal population. The aim of this study was to determine the upper reference limit (URL) of HE4 in a well-defined and large cohort of healthy male individuals and investigate potential factors influencing HE4\nlevels in healthy subjects.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The study included 307 Italian healthy male individuals. HE4 was measured using a chemiluminescent assay (Abbott Laboratories, Wiesbaden, Germany). The URL was calculated using the non-parametric percentile method. Differences in HE4 concentrations according to age, estimated glomerular filtration rate (eGFR), free and bioavailable testosterone were also evaluated.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> The 97.5th percentile URL of serum HE4 in our study population was 57 pmol\/L (90% CI). After stratifying subjects according to age,\nwe found that the URL of HE4 was higher in older (&gt; 50 years) than in younger subjects (18-30 years old), and overlapping with the URL in\nmales from 31 to 50 years old (P=4.769e-16, r=0.44). A strong negative correlation between HE4 and eGFR was observed (P=8.412e-12, r=-\n0.38). Moreover, a statistically significant negative correlation was also found between HE4 and free and bioavailable testosterone.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>In this study was determined the URL of HE4 in a large cohort of healthy male subjects. Our findings indicate that the HE4\nage-dependent differences in males need to be taken into account. The definition of the HE4 URL in males and the correlation observed\nwith eGFR and testosterone should foster the clinical use of HE4 beyond gynecologic cancer.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530320666200807121050","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T06:25:38Z","timestamp":1596867938000},"page":"912-918","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Determination of the Upper Reference Limit of Human Epididymis Secretory Protein 4 (HE4) in Healthy Male Individuals and Correlation with Renal and Fertility Markers"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9826-7907","authenticated-orcid":true,"given":"Annalisa","family":"Schirinzi","sequence":"first","affiliation":[{"name":"Clinic Pathology Unit, Polyclinic University Hospital, Bari,Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0842-7351","authenticated-orcid":true,"given":"Angela Pia","family":"Cazzolla","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Foggia, Foggia,Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0972-4000","authenticated-orcid":true,"given":"Elisa","family":"Mascolo","sequence":"additional","affiliation":[{"name":"Clinic Pathology Unit, Polyclinic University Hospital, Bari,Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5370-419X","authenticated-orcid":true,"given":"Giuseppe","family":"Palmieri","sequence":"additional","affiliation":[{"name":"Private Practice, Milan,Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2882-4226","authenticated-orcid":true,"given":"Francesco","family":"Pesce","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis and Transplantation Unit, DETO, University \"Aldo Moro\", Bari,Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis and Transplantation Unit, DETO, University \"Aldo Moro\", Bari,Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5671-8124","authenticated-orcid":true,"given":"Luigi","family":"Santacroce","sequence":"additional","affiliation":[{"name":"Ionian Department (DJSGEM), Microbiology and Virology Laboratory, University of Bari \"Aldo Moro\", Bari,Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8758-1415","authenticated-orcid":true,"given":"Andrea","family":"Ballini","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Biotechnologies and Biopharmaceutics, Campus Universitario \u201cErnesto Quagliariello\u201d, University of Bari \"Aldo Moro\", Bari,Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7580-5733","authenticated-orcid":true,"given":"Roberto","family":"Lovero","sequence":"additional","affiliation":[{"name":"Clinic Pathology Unit, Polyclinic University Hospital, Bari,Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Di Serio","sequence":"additional","affiliation":[{"name":"Clinic Pathology Unit, Polyclinic University Hospital, Bari,Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1095\/biolreprod45.2.350","volume":"45","author":"Kirchhoff C.","year":"1991","unstructured":"Kirchhoff C.; Habben I.; Ivell R.; Krull N.; A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. Biol Reprod 1991,45(2),350-357","journal-title":"Biol Reprod"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s00404-011-2138-9","volume":"285","author":"Cicinelli E.","year":"2012","unstructured":"Cicinelli E.; Ballini A.; Marinaccio M.; Poliseno A.; Coscia M.F.; Monno R.; De Vito D.; Microbiological findings in endometrial specimen: our experience. Arch Gynecol Obstet 2012,285(5),1325-1329","journal-title":"Arch Gynecol Obstet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1038\/sj.onc.1205363","volume":"21","author":"Bingle L.","year":"2002","unstructured":"Bingle L.; Singleton V.; Bingle C.D.; The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms. Oncogene 2002,21(17),2768-2773","journal-title":"Oncogene"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","volume":"65","author":"Drapkin R.","year":"2005","unstructured":"Drapkin R.; von Horsten H-H.; Lin Y.; Mok S.C.; Crum C.P.; Welch W.R.; Hecht J.L.; Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res 2005,65(6),2162-2169","journal-title":"Cancer Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13048-020-00643-6","volume":"13","author":"Hada A.","year":"2020","unstructured":"Hada A.; Han L.P.; Chen Y.; Hu Q.H.; Yuan Y.; Liu L.; Comparison of the predictive performance of risk of malignancy indexes 1-4, HE4 and risk of malignancy algorithm in the triage of adnexal masses. J Ovarian Res 2020,13(1),46","journal-title":"J Ovarian Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/PGP.0b013e31824fe269","volume":"31","author":"Georgakopoulos P.","year":"2012","unstructured":"Georgakopoulos P.; Mehmood S.; Akalin A.; Shroyer K.R.; Immunohistochemical localization of HE4 in benign, borderline, and malignant lesions of the ovary. Int J Gynecol Pathol 2012,31(6),517-523","journal-title":"Int J Gynecol Pathol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/73432","volume":"24","author":"Ross D.T.","year":"2000","unstructured":"Ross D.T.; Scherf U.; Eisen M.B.; Perou C.M.; Rees C.; Spellman P.; Iyer V.; Jeffrey S.S.; Van de Rijn M.; Waltham M.; Pergamenschikov A.; Lee J.C.; Lashkari D.; Shalon D.; Myers T.G.; Weinstein J.N.; Botstein D.; Brown P.O.; Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000,24(3),227-235","journal-title":"Nat Genet"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1373\/clinchem.2010.157073","volume":"57","author":"Escudero J.M.","year":"2011","unstructured":"Escudero J.M.; Auge J.M.; Filella X.; Torne A.; Pahisa J.; Molina R.; Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases. Clin Chem 2011,57(11),1534-1544","journal-title":"Clin Chem"},{"key":"ref=9","unstructured":"FDA U.S. Food and Drug Administration. Available at:"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/modpathol.3800612","volume":"19","author":"Galgano M.T.","year":"2006","unstructured":"Galgano M.T.; Hampton G.M.; Frierson Jr H.F.; Comprehensive analysis of HE4 expression in normal and malignant human tissues. Mod Pathol 2006,19(6),847-853","journal-title":"Mod Pathol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1465-9921-7-61","volume":"7","author":"Bingle L.","year":"2006","unstructured":"Bingle L.; Cross S.S.; High A.S.; Wallace W.A.; Rassl D.; Yuan G.; Hellstrom I.; Campos M.A.; Bingle C.D.; WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung. Respir Res 2006,7,61","journal-title":"Respir Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s13277-010-0118-5","volume":"32","author":"Yamashita S.","year":"2011","unstructured":"Yamashita S.; Tokuishi K.; Hashimoto T.; Moroga T.; Kamei M.; Ono K.; Miyawaki M.; Takeno S.; Chujo M.; Yamamoto S.; Kawahara K.; Prognostic significance of HE4 expression in pulmonary adenocarcinoma. Tumour Biol 2011,32(2),265-271","journal-title":"Tumour Biol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s13277-012-0427-y","volume":"33","author":"Elsammak M.Y.","year":"2012","unstructured":"Elsammak M.Y.; Attia A.; Hassan H.A.; Zaytoun T.M.; Shorman M.; Suleman M.; Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusion. Tumour Biol 2012,33(5),1701-1707","journal-title":"Tumour Biol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s13277-012-0356-9","volume":"33","author":"Iwahori K.","year":"2012","unstructured":"Iwahori K.; Suzuki H.; Kishi Y.; Fujii Y.; Uehara R.; Okamoto N.; Kobayashi M.; Hirashima T.; Kawase I.; Naka T.; Serum HE4 as a diagnostic and prognostic marker for lung cancer. Tumour Biol 2012,33(4),1141-1149","journal-title":"Tumour Biol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.7754\/Clin.Lab.2018.180222","volume":"64","author":"Mo D.","year":"2018","unstructured":"Mo D.; He F.; Serum human epididymis secretory protein 4 (HE4) is a potential prognostic biomarker in non-small cell lung cancer. Clin Lab 2018,64(9),1421-1428","journal-title":"Clin Lab"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1158\/1055-9965.EPI-14-0447","volume":"23","author":"Karlsen N.S.","year":"2014","unstructured":"Karlsen N.S.; Karlsen M.A.; H\u00f8gdall C.K.; H\u00f8gdall E.V.; HE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors: a systematic review. Cancer Epidemiol Biomarkers Prev 2014,23(11),2285-2295","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref=17","first-page":"5568","volume":"7","author":"Jiang Y.","year":"2014","unstructured":"Jiang Y.; Wang C.; Lv B.; Ma G.; Wang L.; Expression level of serum human epididymis 4 and its prognostic significance in human non-small cell lung cancer. Int J Clin Exp Med 2014,7(12),5568-5572","journal-title":"Int J Clin Exp Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nm.2989","volume":"19","author":"LeBleu V.S.","year":"2013","unstructured":"LeBleu V.S.; Teng Y.; O\u2019Connell J.T.; Charytan D.; M\u00fcller G.A.; M\u00fcller C.A.; Sugimoto H.; Kalluri R.; Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat Med 2013,19(2),227-231","journal-title":"Nat Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"67748","DOI":"10.18632\/oncotarget.11682","volume":"7","author":"Wan J.","year":"2016","unstructured":"Wan J.; Wang Y.; Cai G.; Liang J.; Yue C.; Wang F.; Song J.; Wang J.; Liu M.; Luo J.; Li L.; Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease. Oncotarget 2016,7(42),67748-67759","journal-title":"Oncotarget"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nrneph.2013.2","volume":"9","author":"Allison S.J.","year":"2013","unstructured":"Allison S.J.; Fibrosis: HE4\u2014a biomarker and target in renal fibrosis. Nat Rev Nephrol 2013,9,124","journal-title":"Nat Rev Nephrol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1258\/acb.2011.011258","volume":"49","author":"Nagy B.","year":"2012","unstructured":"Nagy B.; Krasznai Z.T.; Balla H.; Csob\u00e1n M.; Antal-Szalm\u00e1s P.; Hern\u00e1di Z.; Kappelmayer J.; Elevated human epididymis protein 4 concentrations in chronic kidney disease. Ann Clin Biochem 2012,49(Pt 4),377-380","journal-title":"Ann Clin Biochem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"Stevens P.E.","year":"2013","unstructured":"Stevens P.E.; Levin A.; Kidney disease: improving global outcomes chronic kidney disease guideline development work group members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 2013,158(11),825-830","journal-title":"Ann Intern Med"},{"key":"ref=23","unstructured":"National Committee for Clinical Laboratory Standard (NCCLS). Demonstration of Performance for Precision and Accuracy; Approved Guideline. NCCLS document EP15-A (ISBN 1-56238-451-1); NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2001."},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","volume":"84","author":"Vermeulen A.","year":"1999","unstructured":"Vermeulen A.; Verdonck L.; Kaufman J.M.; A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999,84(10),3666-3672","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=25","unstructured":"Clinical Laboratory Standards Institute (CLSI). Defining, establishing, and verifying reference intervals in the clinical laboratory - Approved guideline, Third; CLSI document C28 - A3c. Wayne, PA: CLSI, 2008."},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s13277-011-0256-4","volume":"33","author":"Bolstad N.","year":"2012","unstructured":"Bolstad N.; \u00d8ijordsbakken M.; Nustad K.; Bjerner J.; Human epididymis protein 4 reference limits and natural variation in a Nordic reference population. Tumour Biol 2012,33(1),141-148","journal-title":"Tumour Biol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cca.2018.05.006","volume":"483","author":"Luo J.","year":"2018","unstructured":"Luo J.; Wang F.; Wan J.; Ye Z.; Huang C.; Cai Y.; Liu M.; Wu B.Q.; Li L.; Serum human epididymis secretory protein 4 as a potential biomarker of renal fibrosis in kidney transplantation recipients. Clin Chim Acta 2018,483,216-221","journal-title":"Clin Chim Acta"},{"key":"ref=28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128836","volume":"10","author":"Lamy P.J.","year":"2015","unstructured":"Lamy P.J.; Plassot C.; Pujol J.L.; Serum HE4: an independent prognostic factor in non-small cell lung cancer. PLoS One 2015,10(6)","journal-title":"PLoS One"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cardfail.2016.05.002","volume":"23","author":"Piek A.","year":"2017","unstructured":"Piek A.; Meijers W.C.; Schroten N.F.; Gansevoort R.T.; de Boer R.A.; Sillj\u00e9 H.H.W.; HE4 serum levels are associated with heart failure severity in patients with chronic heart failure. J Card Fail 2017,23(1),12-19","journal-title":"J Card Fail"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/jcla.21954","volume":"30","author":"Yang Z.","year":"2016","unstructured":"Yang Z.; Zhang Z.; Qin B.; Wu P.; Zhong R.; Zhou L.; Liang Y.; Human epididymis protein 4: a novel biomarker for lupus nephritis and chronic kidney disease in systemic lupus erythematosus. J Clin Lab Anal 2016,30(6),897-904","journal-title":"J Clin Lab Anal"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.clinbiochem.2013.08.019","volume":"46","author":"Yang J.","year":"2013","unstructured":"Yang J.; Sa M.; Huang M.; Yang J.; Xiang Z.; Liu B.; Tang A.; The reference intervals for HE4, CA125 and ROMA in healthy female with electrochemiluminescence immunoassay. Clin Biochem 2013,46(16-17),1705-1708","journal-title":"Clin Biochem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.19193\/0393-6384_2016_6_182","volume":"32","author":"Di Serio F.","year":"2016","unstructured":"Di Serio F.; Lovero R.; D\u2019Agostino D.; Nisi L.; Miragliotta G.; Contino R.; Man A.; Ciccone M.M.; Santacroce L.; Evaluation of procalcitonin, Vitamin D and C-reactive protein levels in septic patients with positive emocoltures. Our preliminary experience. Acta Med Mediter 2016,32,1911-1914","journal-title":"Acta Med Mediter"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3109\/15569527.2015.1055495","volume":"35","author":"Foti C.","year":"2016","unstructured":"Foti C.; Romita P.; Rigano L.; Zimerson E.; Sicilia M.; Ballini A.; Ghizzoni O.; Antelmi A.; Angelini G.; Bonamonte D.; Bruze M.; Isobornyl acrylate: an impurity in alkyl glucosides. Cutan Ocul Toxicol 2016,35(2),115-119","journal-title":"Cutan Ocul Toxicol"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/184628","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184628\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/184628","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T06:41:56Z","timestamp":1648449716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184628\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530320666200807121050","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-03-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}